GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,803.50p
   
  • Change Today:
      20.50p
  • 52 Week High: 1,833.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,077.25m
  • Volume: 6,939,993
  • Market Cap: £73,533m
  • RiskGrade: 129
  • Beta: 0.93

Latest ShareCast News

GSK's lung cancer drug granted orphan status by FDA

By Benjamin Chiou

Date: Wednesday 10 Dec 2025

(Sharecast News) - GSK's risvutatug rezetecan has received Orphan Drug Designation from US regulators for the treatment of small-cell lung cancer, the UK pharma group announced on Wednesday.

GSK ShareCast News

Berenberg raises target price on GSK 25-Nov-2025 ShareCast
GSK files suit against AnaptysBio over licensing... 21-Nov-2025 ShareCast
GSK posts better-than-expected Q3, upgrades guid... 29-Oct-2025 ShareCast
GSK lung cancer treatment gets EU orphan drug st... 28-Oct-2025 ShareCast
GSK shares lift on £268m prostate cancer deal 27-Oct-2025 ShareCast

GSK Regulatory News

GSK'227 US FDA Orphan Drug Designation in SCLC 10-Dec-2025 07:00 RNS
Transaction in Own Shares 10-Dec-2025 07:00 RNS
Director/PDMR Shareholding 09-Dec-2025 15:30 RNS
Transaction in Own Shares 09-Dec-2025 07:00 RNS
Transaction in Own Shares 08-Dec-2025 07:00 RNS

GSK Newspaper Links

GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph
GlaxoSmithKline tops table in effort to get drug... 17-Nov-2014 Guardian

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,803.50p
Change Today 20.50p
% Change 1.15 %
52 Week High 1,833.00
52 Week Low 1,264.00
Volume 6,939,993
Shares Issued 4,077.25m
Market Cap £73,533m
Beta 0.93
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 14
Sell 2
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 13-Nov-25 14-Aug-25
Paid 08-Jan-26 09-Oct-25
Amount 16.00p 16.00p

Trades for 10-Dec-2025

Time Volume / Share Price
16:48 29,309 @ 1,803.50p
16:48 361 @ 1,803.50p
16:47 74,408 @ 1,799.14p
16:37 220,000 @ 1,789.73p
16:38 1,942 @ 1,803.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page